Oxidative modification induced by photodynamic therapy with Photofrin® II and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells

Abstract Ovarian cancer is among the most lethal cancers in women. The successful anticancer treatment depends on the effectiveness of cytotoxic effect of applied therapeutic procedures either alone or in combination with other treatments. Photodynamic therapy (PDT) is a relatively new method of ant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biomedicine & pharmacotherapy 2015-04, Vol.71, p.30-36
Hauptverfasser:	Saczko, Jolanta, Choromańska, Anna, Rembiałkowska, Nina, Dubińska-Magiera, Magda, Bednarz-Misa, Iwona, Bar, Julia, Marcinkowska, Anna, Kulbacka, Julita
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Methoxyestradiol Adenocarcinoma - drug therapy Adenocarcinoma - pathology Blotting, Western Breast adenocarcinoma Breast Neoplasms - drug therapy Breast Neoplasms - pathology Cell Line, Tumor Cytoskeleton Cytoskeleton - drug effects Cytoskeleton - metabolism Dihematoporphyrin Ether - pharmacology Dihematoporphyrin Ether - therapeutic use Estradiol - analogs & derivatives Estradiol - pharmacology Estradiol - therapeutic use Female Heat shock proteins HSP27 Heat-Shock Proteins - metabolism HSP70 Heat-Shock Proteins - metabolism Humans Immunohistochemistry Internal Medicine Medical Education Nitric Oxide Synthase Type II - metabolism Ovarian carcinoma Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Oxidation-Reduction - drug effects Photochemotherapy Photodynamic reaction Photofrin®II
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!